DOCS

Doximity Inc
NYSEHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$4.70B
P/E Ratio
32.13
EPS
$0.82
Beta
1.25
52W High
$75.44
52W Low
$17.15
50-Day MA
$24.35
200-Day MA
$27.31
Dividend Yield
—
Profit Margin
25.50%
Forward P/E
19.76
PEG Ratio
0.59

About Doximity Inc

Doximity, Inc. (Ticker: DOCS) is a U.S. healthcare technology company that operates a digital platform tailored for medical professionals. The company’s cloud-based network provides secure communication and collaboration tools, telemedicine services, clinical workflow solutions, and access to medical news, research, and career-management features for physicians, nurse practitioners, physician assistants, and other clinicians. Headquartered in San Francisco, California, Doximity’s Class A common stock trades on the New York Stock Exchange under the ticker DOCS.

Official WebsiteUSAFY End: March

Fundamentals

Revenue (TTM)$655.57M
Gross Profit (TTM)$577.34M
EBITDA$208.40M
Operating Margin21.50%
Return on Equity17.20%
Return on Assets11.00%
Revenue/Share (TTM)$3.53
Book Value$5.09
Price-to-Book5.17
Price-to-Sales (TTM)7.16
EV/Revenue6.19
EV/EBITDA19.33
Quarterly Earnings Growth (YoY)-51.90%
Quarterly Revenue Growth (YoY)7.30%
Shares Outstanding$127.35M
Float$123.64M
% Insiders2.86%
% Institutions102.95%

Historical Volatility

HV 10-Day
32.40%
HV 20-Day
44.67%
HV 30-Day
45.33%
HV 60-Day
73.89%
HV Rank
44.0%

Volatility is currently contracting

Analyst Ratings

Consensus ($29.94 target)
5
Strong Buy
4
Buy
10
Hold
1
Sell
1
Strong Sell

Latest News

DOCS DEADLINE: Levi & Korsinsky Reminds Doximity, Inc. Investors of Upcoming Securities Class Action Deadline

Doximity's CEO and former CFO are named as alleged controlling persons in a securities class action claiming the Company overstated how much its "Newsfeed" product drove revenue growth while allegedly losing market share to competitors Doximity's CEO and former CFO are named as alleged controlling persons in a securities class action claiming the Company overstated how much its "Newsfeed" product drove revenue growth while allegedly losing market share to competitors

GlobeNewsWire9/28/2026Neutral
Kaplan Fox Alerts Doximity, Inc. (DOCS) Investors Who Suffered Losses to a Securities Class Action - Deadline Is November 16, 2026

New York, New York--(Newsfile Corp. - September 28, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS) on behalf of investors that purchased or otherwise acquired Doximity common stock between August 8, 2024 and May 13, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Doximity and have suffered losses, you may CLICK HERE to contact us.

Newsfile Corp9/28/2026Neutral
Deadline Soon: Doximity, Inc. (DOCS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming November 16, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) securities between August 8, 2024 and May 13, 2026, inclusive (the “Class Period”).IF YOU ARE AN INVESTOR WHO LOST MONEY ON DOXIMITY, INC. (DOCS), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAUD.

Business Wire9/25/2026Neutral
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Sept. 25, 2026 (GLOBE NEWSWIRE) --  Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (NYSE: DOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

GlobeNewsWire9/25/2026Neutral
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

New York, New York--(Newsfile Corp. - September 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

Newsfile Corp9/25/2026Neutral
ROSEN, A TOP-RANKED LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS

NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 16, 2026.

GlobeNewsWire9/25/2026Neutral
Kaplan Fox Reminds Doximity, Inc. (DOCS) Investors with Significant Losses to Seek a Leadership Role Before Deadline on November 16, 2026

New York, New York--(Newsfile Corp. - September 24, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS) on behalf of investors that purchased or otherwise acquired Doximity common stock between August 8, 2024 and May 13, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Doximity and have suffered losses, you may CLICK HERE to contact us.

Newsfile Corp9/24/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on DOCS and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 9/28/2026